Matrix metalloproteinase-9 as a marker for acute ischemic stroke: a systematic review.
about
The Role of Matrix Metalloproteinase Polymorphisms in Ischemic StrokeImplications of MMP9 for Blood Brain Barrier Disruption and Hemorrhagic Transformation Following Ischemic StrokeNeurovascular unit dysfunction with blood-brain barrier hyperpermeability contributes to major depressive disorder: a review of clinical and experimental evidenceAge and the metabolic syndrome as risk factors for ischemic stroke: improving preclinical models of ischemic strokeThe Concise Guide to PHARMACOLOGY 2013/14: enzymes.A biochemical marker panel in MRI-proven hyperacute ischemic stroke-a prospective study.Infrared optical imaging of matrix metalloproteinases (MMPs) up regulation following ischemia reperfusion is ameliorated by hypothermia.Resveratrol neuroprotection in stroke and traumatic CNS injury.Correlation of circulating MMP-9 with white blood cell count in humans: effect of smoking.TAK-242, an antagonist for Toll-like receptor 4, protects against acute cerebral ischemia/reperfusion injury in miceUnbalanced Metalloproteinase-9 and Tissue Inhibitors of Metalloproteinases Ratios Predict Hemorrhagic Transformation of Lesion in Ischemic Stroke Patients Treated with Thrombolysis: Results from the MAGIC Study.Serum tissue inhibitor of matrix metalloproteinase-1 levels are associated with mortality in patients with malignant middle cerebral artery infarctionUnraveling the ischemic brain transcriptome in a permanent middle cerebral artery occlusion mouse model by DNA microarray analysis.Remote ischemic preconditioning in the prevention of ischemic brain damage during intracranial aneurysm treatment (RIPAT): study protocol for a randomized controlled trial.Evaluation of New Diagnostic Biomarkers in Pediatric Sepsis: Matrix Metalloproteinase-9, Tissue Inhibitor of Metalloproteinase-1, Mid-Regional Pro-Atrial Natriuretic Peptide, and Adipocyte Fatty-Acid Binding ProteinMatrix metalloproteinase-2 or -9 deletions protect against hemorrhagic transformation during early stage of cerebral ischemia and reperfusion.Association between arsenic exposure from drinking water and plasma levels of cardiovascular markersEndothelial cells and astrocytes: a concerto en duo in ischemic pathophysiology.Matrix metalloproteinase 9-mediated intracerebral hemorrhage induced by cerebral amyloid angiopathy.Does inhibiting Sur1 complement rt-PA in cerebral ischemia?Association of dimethylarginines and mediators of inflammation after acute ischemic strokeNew biomarkers for stage determination in Trypanosoma brucei rhodesiense sleeping sickness patientsMatrix Metalloprotease 3 Exacerbates Hemorrhagic Transformation and Worsens Functional Outcomes in Hyperglycemic StrokeMatrix metalloproteinases and blood-brain barrier disruption in acute ischemic stroke.2-Chloroethanol Induced Upregulation of Matrix Metalloproteinase-2 in Primary Cultured Rat Astrocytes Via MAPK Signal Pathways.Mmp-9 inhibition: a therapeutic strategy in ischemic stroke.One-Compound-Multi-Target: Combination Prospect of Natural Compounds with Thrombolytic Therapy in Acute Ischemic Stroke.Lp(a)/apo(a) modulate MMP-9 activation and neutrophil cytokines in vivo in inflammation to regulate leukocyte recruitment.Blood-brain barrier in acute liver failureSerum levels of matrix metalloproteinases: implications in clinical neurology.Novel cardiac-specific biomarkers and the cardiovascular continuum.Targeting reactive nitrogen species: a promising therapeutic strategy for cerebral ischemia-reperfusion injury.Potential blood biomarkers for stroke.Malignant cerebral edema after large anterior circulation infarction: a review.MMP-9 in translation: from molecule to brain physiology, pathology, and therapy.Optimization of time for neural stem cells transplantation for brain stroke in rats.Temporal analysis of blood-brain barrier disruption and cerebrospinal fluid matrix metalloproteinases in rhesus monkeys subjected to transient ischemic stroke.Upregulation of Matrix Metalloproteinase-9 in Primary Cultured Rat Astrocytes Induced by 2-Chloroethanol Via MAPK Signal PathwaysNew approach to identify ischemic stroke patients at risk to develop hemorrhagic transformation.Loss of Integrity: Impairment of the Blood-brain Barrier in Heavy Metal-associated Ischemic Stroke.
P2860
Q26741200-7BCBEB41-B30E-43E2-AC7C-2FDB03DC18ACQ26766038-2F544A5D-B6EB-4479-9875-3D8A10243FE4Q26999061-20C39F30-3EAB-4A25-8B3D-9D0E9BEF2980Q28391839-1251AE09-52AA-4000-9398-84055CB05EC3Q30486745-4FD4AAF3-A7C8-46DF-B5DC-7CB0D97378E9Q31050144-BE5A5948-A9D8-4D75-8A82-C21A25CFFC48Q34319977-542C4B1E-DDD1-45FF-8019-AB22A90E6A4EQ34489690-E43C3FC4-54BD-448C-9DF3-07DA3400F762Q34794044-2AA3B396-CA2E-441F-ACB7-D0F90371A29CQ35572877-77478D64-C97C-4A9E-A18B-B12D165B7B82Q35652269-A5C3BCB1-85F1-4C97-A357-49D29B14F8B2Q35688512-85F96157-AF73-4CD3-8EBC-57A031612500Q35794591-1253B428-86C7-4C89-9890-F8BC8E39F262Q35881011-3334D45E-3E8D-48C7-80F9-EE8FB89639D9Q35992557-4087D2E1-E42A-4941-A8FA-F2D5F4495F5CQ36007470-F51AE7C2-EBF2-4F98-87FA-8151703B5834Q36023464-E55C442C-5BCB-4666-8681-EAD906E2320BQ36072867-ECCB56F0-349F-40F8-8B42-D7418B52D6C2Q36173578-0B8BCF0B-7CF7-4699-84E7-02219C649F26Q36426567-9391CAC6-8BC1-49F8-AAD9-CA730094B096Q36498512-063FDE24-2F7C-4168-9B99-A297AEE2803DQ36578354-E30086C4-9DB7-4972-9EFB-020C10E36F78Q36614594-B85315C6-C5FC-40C5-9FA5-269130CF46D5Q36736442-0E3DEA91-5A96-4755-8B5D-473E48EF2967Q37553275-B97432D1-3A24-41C6-BF9A-9B23EEF51A75Q37568882-1994CA22-86D6-4EAD-8BF6-F0E42DBE132FQ37668019-6397719F-3780-4EB4-BB23-D9AF5031E998Q37734908-A911248A-B808-4A86-9A58-EEB4F7391323Q37958501-7BB9B021-96EB-45E0-9545-BAEFAC2349E9Q37977361-55FDE485-893B-4E30-995E-CC5F6EE591D3Q38009305-5BEEF03F-E798-465E-AF20-F2700F0B3137Q38030379-C7E65374-36F5-4AB0-84D5-1AAF0EBE85CAQ38042459-285CF59B-EBA6-4872-83A9-F6CF96AC6658Q38175890-60F54FB4-7230-452B-881B-71DF6C257F4BQ38622769-9CC7EF02-E314-4CE7-8705-D4DA9CB709BEQ38771914-A6A4526C-B278-4767-B2E0-9B2C74848FADQ39155405-6E181E88-D77F-44A3-BCC9-33BB6C84D409Q41052025-C56ABE60-7914-4B0F-B13A-B3E03616FF09Q41362038-B2DA8FBC-F3BC-4F25-9D51-D9DCAC67CC65Q41845503-2D58C742-4056-4EB0-84CB-818ECF3EB882
P2860
Matrix metalloproteinase-9 as a marker for acute ischemic stroke: a systematic review.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 17 June 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Matrix metalloproteinase-9 as a marker for acute ischemic stroke: a systematic review.
@en
Matrix metalloproteinase-9 as a marker for acute ischemic stroke: a systematic review.
@nl
type
label
Matrix metalloproteinase-9 as a marker for acute ischemic stroke: a systematic review.
@en
Matrix metalloproteinase-9 as a marker for acute ischemic stroke: a systematic review.
@nl
prefLabel
Matrix metalloproteinase-9 as a marker for acute ischemic stroke: a systematic review.
@en
Matrix metalloproteinase-9 as a marker for acute ischemic stroke: a systematic review.
@nl
P1476
Matrix metalloproteinase-9 as a marker for acute ischemic stroke: a systematic review.
@en
P2093
M Fernanda Bellolio
Maria Ramos-Fernandez
P356
10.1016/J.JSTROKECEREBROVASDIS.2009.10.008
P577
2010-06-17T00:00:00Z